The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Glaxo Buys Nabi Staph Infection Vaccine for $46M

August 7, 2009 5:21 am | News | Comments

NEW YORK (AP) — Nabi Biopharmaceuticals said Thursday it sold its staph infection vaccine PentaStaph to British drugmaker GlaxoSmithKline PLC in a deal worth as much as $46 million.


Merck Takeover of Schering-Plough up for Vote

August 7, 2009 5:18 am | News | Comments

LINDA A. JOHNSON AP Business Writer TRENTON, N.J. (AP) — Shareholders of Merck & Co. and Schering-Plough Corp. will decide Friday whether to combine their companies into the world's second-biggest drugmaker.


Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccineto FDA

August 7, 2009 5:15 am | News | Comments

Sanofi Pasteur,the vaccines division of the sanofi-aventis Group has submitted to the FDA a supplemental application for licensure of its influenzaA(H1N1) 2009 monovalent vaccine.


FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, Antihemophilic Factor (recombinant)

August 7, 2009 5:03 am | News | Comments

Bayer HealthCarePharmaceuticals has announced that the FDA hasapproved a 3000 IU (international unit) vial size of Kogenate FS,antihemophilic factor (recombinant). The new vial size offers greaterconvenience for patients with hemophilia A who require a higher dose.


Sanofi Pasteur Starts Testing Swine Flu Vaccine in 2,000 People in the US

August 7, 2009 4:59 am | News | Comments

Maria Cheng THE ASSOCIATED PRESS LONDON — Sanofi Pasteur began human trials of its swine flu vaccine this week in about 2,000 people in the United States, the company said Friday — becoming the third company conducting clinical trials on swine flu vaccines.


European Commission And U.S. Fda Grant Alexion's Soliris® (Eculizumab) Orphan Drug Designation For The Treatment Of Atypical Hemolytic Uremic Syndrome (Ahus)

August 6, 2009 9:06 am | News | Comments

Alexion Pharmaceuticals, Inc. has announced today that Soliris® (eculizumab), its first-in-class complement inhibitor, has been granted Orphan Medicinal Product Designation by the European Commission for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS).


FDA Issues Pharmaceutical Industry Guidance on Preventing Melamine Contamination

August 6, 2009 7:11 am | News | Comments

In a guidance issued today, the FDA says that certain pharmaceutical ingredients used in the manufacture or preparation of drug products should be tested for melamine.


Pressure Gauge Takes Measurements In Harsh Media Applications

August 6, 2009 5:27 am | Product Releases | Comments

The Type 5503 differential pressure gauge provides reliable low differential pressure measurement in high static, wet-wet pressure applications.


Alnylam and Tekmira Participate in New Research Collaboration

August 6, 2009 5:17 am | News | Comments

Alnylam Pharmaceuticals, Inc., an RNAi therapeutics company, and Tekmira Pharmaceuticals Corporation, will jointly participate in a new research collaboration focused on the discovery of novel cationic lipids and lipid nanoparticles for the systemic delivery of RNAi therapeutics.


Teva: Court Backs Overturn of Yasmin Patent

August 6, 2009 4:45 am | News | Comments

NEW YORK (AP) — Teva Pharmaceutical Industries Ltd. said Wednesday a U.S. Court backed a ruling that overturned a patent behind Bayer Schering's birth control pill Yasmin. Teva said the U.S. Court of Appeals for the Federal Circuit supported an earlier ruling made by the U.S.


Seasonal Flu Vaccine Shipping Early, Demand Up

August 6, 2009 4:33 am | News | Comments

LINDA A. JOHNSON AP Business Writer TRENTON, N.J. (AP) — The swine flu pandemic is spurring makers of seasonal flu vaccines to ship them to the U.S. market well ahead of schedule, and supplies are tightening as distributors and others snap up vaccine vials. The top U.S.


Novo Nordisk Posts Rise in 2Q Profits

August 6, 2009 4:27 am | News | Comments

COPENHAGEN (AP) — Danish drug maker Novo Nordisk A/S on Thursday said second-quarter net profit rose by 21 percent, aided by a surge in insulin sales in North America.


New Lilly Blood Thinner Finally Reaches US Pharmacies

August 5, 2009 12:11 pm | News | Comments

INDIANAPOLIS (AP) — Eli Lilly and Co. said Wednesday the blood thinner Effient has finally reached U.S. pharmacy shelves. The Indianapolis company said Effient is now available across the United States.


Impax Gets Approval For Generic Seizure Drug

August 5, 2009 12:04 pm | News | Comments

HAYWARD, Calif. (AP) — Impax Laboratories Inc. said Wednesday it received FDA approval for a 500-milligram version of the seizure drug Depakote ER. Abbott Laboratories makes Depakote ER, which is used as a treatment for epilepsy and bipolar disorders.


Novavax Says it Synthesized Swine Flu for Vaccine

August 5, 2009 6:54 am | News | Comments

ROCKVILLE, Md. (AP) — Novavax Inc. said Wednesday it created a version of the swine flu virus for use in a potential vaccine. Using a gene sequence provided by the U.S.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.